172 related articles for article (PubMed ID: 24309000)
1. Synthesis, characterization and anticancer screening of some novel piperonyl-tetrazole derivatives.
Arshad M; Bhat AR; Pokharel S; Kim JE; Lee EJ; Athar F; Choi I
Eur J Med Chem; 2014 Jan; 71():229-36. PubMed ID: 24309000
[TBL] [Abstract][Full Text] [Related]
2. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel tetrazole containing hybrid ciprofloxacin and pipemidic acid analogues and preliminary biological evaluation of their antibacterial and antiproliferative activity.
Dileep K; Polepalli S; Jain N; Buddana SK; Prakasham RS; Murty MSR
Mol Divers; 2018 Feb; 22(1):83-93. PubMed ID: 29138963
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiproliferative evaluation of 5-oxo and 5-thio derivatives of 1,4-diaryl tetrazoles.
Gundugola AS; Chandra KL; Perchellet EM; Waters AM; Perchellet JP; Rayat S
Bioorg Med Chem Lett; 2010 Jul; 20(13):3920-4. PubMed ID: 20627565
[TBL] [Abstract][Full Text] [Related]
6. Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent.
Mokale SN; Sakle NS; Bhavale SA; Lokwani DK; Shelke VR
Anticancer Agents Med Chem; 2018; 18(7):1009-1015. PubMed ID: 29189180
[TBL] [Abstract][Full Text] [Related]
7. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
8. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-breast cancer activity of new indolylquinone derivatives.
Li X; Zheng SL; Li X; Li JL; Qiang O; Liu R; He L
Eur J Med Chem; 2012 Aug; 54():42-8. PubMed ID: 22658083
[TBL] [Abstract][Full Text] [Related]
10. Tetrazole Derivatives as Promising Anticancer Agents.
Popova EA; Protas AV; Trifonov RE
Anticancer Agents Med Chem; 2018 Feb; 17(14):1856-1868. PubMed ID: 28356016
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs.
El-Sayed WA; El-Kosy SM; Ali OM; Emselm HM; Abdel-Rahman AA
Acta Pol Pharm; 2012; 69(4):669-77. PubMed ID: 22876609
[TBL] [Abstract][Full Text] [Related]
12. Microwave-assisted synthesis of sec/tert-butyl 2-arylbenzimidazoles and their unexpected antiproliferative activity towards ER negative breast cancer cells.
Abdul Rahim AS; Salhimi SM; Arumugam N; Pin LC; Yee NS; Muttiah NN; Keat WB; Abd Hamid S; Osman H; Mat Ib
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1255-60. PubMed ID: 23061895
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel benzo[4,5]thiazolo[1,2-a]pyrimidine-3-carboxylate derivatives and biological evaluation as potential anticancer agents.
Nagarapu L; Vanaparthi S; Bantu R; Ganesh Kumar C
Eur J Med Chem; 2013 Nov; 69():817-22. PubMed ID: 24113366
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.
Khan AA; Alanazi AM; Jabeen M; Chauhan A; Abdelhameed AS
Anticancer Res; 2013 Jun; 33(6):2517-24. PubMed ID: 23749903
[TBL] [Abstract][Full Text] [Related]
15. Behavior-selective apoptotic capacity of 4-(3,4,5-Trimethoxyphenoxy) benzoic acid and its methyl derivatives on two breast cancer cell lines.
Lee KH; Ho WY; Wu SJ; Cheng TL; Huang PJ; Wang CC; Hung JH
Anticancer Res; 2014 Apr; 34(4):1801-9. PubMed ID: 24692713
[TBL] [Abstract][Full Text] [Related]
16. Characterization of lovastatin-docosahexaenoate anticancer properties against breast cancer cells.
Siddiqui RA; Harvey KA; Xu Z; Natarajan SK; Davisson VJ
Bioorg Med Chem; 2014 Mar; 22(6):1899-908. PubMed ID: 24556504
[TBL] [Abstract][Full Text] [Related]
17. Tetrazole hybrids with potential anticancer activity.
Zhang J; Wang S; Ba Y; Xu Z
Eur J Med Chem; 2019 Sep; 178():341-351. PubMed ID: 31200236
[TBL] [Abstract][Full Text] [Related]
18. H2O-mediated isatin spiro-epoxide ring opening with NaCN: Synthesis of novel 3-tetrazolylmethyl-3-hydroxy-oxindole hybrids and their anticancer evaluation.
Sharma P; Senwar KR; Jeengar MK; Reddy TS; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Nov; 104():11-24. PubMed ID: 26413726
[TBL] [Abstract][Full Text] [Related]
19. A novel tetrazole analogue of resveratrol is a potent anticancer agent.
Bommagani S; Penthala NR; Balasubramaniam M; Kuravi S; Caldas-Lopes E; Guzman ML; Balusu R; Crooks PA
Bioorg Med Chem Lett; 2019 Jan; 29(2):172-178. PubMed ID: 30528695
[TBL] [Abstract][Full Text] [Related]
20. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
